For those of us who have been following Dr. Fasano's progress in developing and testing a pill to counter zolulin, and thereby keep the "tight junctions" in the epithelia of the intestines closed, here's a recent report with news that the project is still on track:
http://www.medicalnewstoday.com/articles/124585.php
Also, note the phrase from that report, suggesting that the product, larazotide acetate, (AT-1001), may also be useful as a treatment for IBDs. How about that?
If you want some background information on the theory involved, and the company that he co-founded to develop and market the product, here's an article from a couple of years ago:Results from a second poster presented at ACG showed that larazotide acetate also inhibited the effect of inflammatory cytokines, including tumor necrosis factor (TNF-alpha) and interleukin (IL-4) on intestinal epithelial permeability, in vitro, further suggesting that the product offers potential as a future treatment for inflammatory bowel disease (IBD).
http://www.albatherapeutics.com/Default.aspx?tabid=178
When this product finally receives FDA approval, and hits the market, it will probably be the closest thing to "magic" that we will ever see in our lifetimes.
Tex

Visit the Microscopic Colitis Foundation Website

